Preclinical Models

Cells in the intestine
© Fraunhofer IZI

The Preclinical Model Unit is concerned with the design and implementation of preclinical efficacy and safety studies for new drug candidates under GLP or GLP-analogous conditions. This includes the development, establishment and validation of in-vitro and in-vivo models for inflammatory and tumorigenic diseases. The main focus of research is on the development and optimization of humanized mouse models for developing and testing patient-specific therapies.



Here we show you a selection of current and completed projects.


Here you will find an overview of all publications that have emerged from the research work of our unit.